Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma

Mengwei Li(China Pharmaceutical University), Hanmei Xu(China Pharmaceutical University)

Molecular Cancer

September 19, 2022

10.1186/s12943-022-01654-1

Cited by 79

Related Papers

Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors

|Molecular Cancer|2018|99

Novel production method of innovative antiangiogenic and antitumor small peptides in <em>Escherichia coli</em>

|Drug Design Development and Therapy|2017|9

Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase-and phosphoinositide 3-kinase-associated pathways

|Molecular Medicine Reports|2015|8

A Novel Nuclear-Localized Micropeptide, MP60, Promotes Hepatocellular Carcinoma Progression via the Epithelial-Mesenchymal Transition

|Cancers|2025|0